Passage BIO (PASG) Income towards Parent Company (2019 - 2026)

Passage BIO's Income towards Parent Company history runs 8 years deep, the most recent figure standing at -$15.7 million for Q1 2026.

• In Q1 2026, Income towards Parent Company rose 50.27% year-over-year to -$15.7 million; the TTM figure through Mar 2026 stood at -$139.2 million (up 61.65% YoY), while the FY2025 annual figure was -$272.1 million, up 6.25% from the prior year.
• Income towards Parent Company for Q1 2026 stood at -$15.7 million, up from -$27.1 million in the prior quarter.
• The five-year high for Income towards Parent Company was -$15.7 million in Q1 2026, with the low at -$234.1 million in Q4 2024.
• The 5-year median for Income towards Parent Company is -$55.5 million (2023), against an average of -$82.2 million.
• The sharpest annual moves came in 2022 and 2025: Income towards Parent Company plunged 121.83% in 2022, then soared 88.41% in 2025.
• Passage BIO's Income towards Parent Company stood at -$207.6 million in 2022, then decreased by 5.53% to -$219.1 million in 2023, then retreated by 6.87% to -$234.1 million in 2024, then jumped by 88.41% to -$27.1 million in 2025, then surged by 42.17% to -$15.7 million in 2026.
• Business Quant data shows PASG's Income towards Parent Company at -$15.7 million in Q1 2026, -$27.1 million in Q4 2025, and -$46.9 million in Q3 2025.